Roche’s Evrysdi improves motor functions in infants with SMA
Evrysdi lowered mortality rate in infants with type 1 SMA. Credit: Christian Abella from Pixabay.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more